BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar]. 2013

L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Service des maladies infectieuses et tropicales Ibrahima Diop Mar, CHNU Fann, Dakar, Sénégal, louisefortes@yahoo.fr.

We conducted a study to evaluate the tolerance of the zidovudine (AZT), lamivudine (3TC) and nevirapine (NVP) combination regimen in HIV-1 patients by a descriptive analytical retrospective study of all HIV-1 patients receiving AZT-3TC-NVP combination between 2008 and 2011. Seventy patients were included. Two thirds of the patients presented at least one side effect (44 cases). The digestive disorders (15 cases) and neuropsychiatric (14 cases) were the most frequent. Epigastralgia (20%), headaches (20%) and arthralgias (13%) were main side effects. A maculo-papular exanthema was noted in three cases. During the follow-up, five patients presented with anemia. No patient presented hepatic cytolysis due to NVP. All the patients followed for more than six months presented a side effect against 29.7% when the duration of treatment was equal to or less than 6 months (p=10(-5)). Most of the side effects due to the association AZT/3TC/NVP are minor. The evaluation of the clinical and biological tolerance must be maintained during all the follow-up.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006784 Hospitals, Teaching Hospitals engaged in educational and research programs, as well as providing medical care to the patients. Hospital, Teaching,Teaching Hospital,Teaching Hospitals
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012675 Senegal A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar. Republic of Senegal
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Clinical, Immunological and Virological Responses of Zidovudine-Lamivudine-Nevirapine versus Zidovudine-Lamivudine-Efavirenz Antiretroviral Treatment (ART) Among HIV-1 Infected Children: Asella Teaching and Referral Hospital, South-East Ethiopia.
January 2018, The open medical informatics journal,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
[Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in Dakar, Senegal].
May 2009, Bulletin de la Societe de pathologie exotique (1990),
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
[Pneumocystis pneumonia biological diagnosis at Fann Teaching Hospital in Dakar, Senegal].
March 2016, Journal de mycologie medicale,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
[Resistance of bacteria and antibiotic prescription in Fann University Teaching Hospital, Dakar].
January 2003, Dakar medical,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Sleep quality assessment in 35 Parkinson's disease patients in the Fann Teaching Hospital, Dakar, Senegal.
March 2016, Revue neurologique,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Pre-hospital delay in patients with ischemic stroke in the Fann Teaching Hospital, Dakar, Senegal in 2020.
January 2022, The Pan African medical journal,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
April 2004, Antiviral therapy,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
January 2011, Antiviral therapy,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
April 2001, JAMA,
L Fortes Déguénonvo, and S A Diop, and M M M Leye, and M Seydi, and A B Dieng, and H Bentaleb, and A Diouf, and N A Lakhe, and D Ka, and V M P Cisse, and N M Dia Badiane, and M N Manga, and C T Ndour, and M Soumaré, and B M Diop, and P S Sow
GW420867X administered to HIV-1-infected patients alone and in combination with lamivudine and zidovudine.
January 2001, HIV clinical trials,
Copied contents to your clipboard!